Severe psoriasis pustulosa palmaris et plantaris (Barber?K�nigsbeck) treated successfully with soluble tumour necrosis factor receptor fusion protein (etanercept)

Psoriasis Pustulosa ◽

A pilot study of the recombinant soluble human tumour necrosis factor receptor (p75)-Fc fusion protein in patients with myelodysplastic syndrome

British Journal of Haematology ◽

10.1046/j.1365-2141.2002.03381.x ◽

2002 ◽

Vol 117 (1) ◽

pp. 119-126 ◽

Cited By ~ 43

Author(s):

Jaroslaw P. Maciejewski ◽

Antonio M. Ristiano ◽

Elaine M. Sloand ◽

Laura Wisch ◽

Nancy Geller ◽

...

Keyword(s):

Pilot Study ◽

Fusion Protein ◽

Myelodysplastic Syndrome ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Human Tumour ◽

Fc Fusion Protein ◽

Human Tumour Necrosis Factor ◽

Effects of therapy with soluble tumour necrosis factor receptor fusion protein on pulmonary cytokine expression and lung injury following haemorrhage and resuscitation

Clinical & Experimental Immunology ◽

10.1111/j.1365-2249.1994.tb06602.x ◽

2008 ◽

Vol 98 (1) ◽

pp. 29-34 ◽

Cited By ~ 15

Author(s):

E. ABRAHAM ◽

W. F. COULSON ◽

M. D. SCHWARTZ ◽

J. ALLBEE

Keyword(s):

Lung Injury ◽

Fusion Protein ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Cytokine Expression ◽

Prospective study of anti-tumour necrosis factor receptor superfamily 1B fusion protein, and case study of anti-tumour necrosis factor receptor superfamily 1A fusion protein, in tumour necrosis factor receptor associated periodic syndrome (TRAPS): clinical and laboratory findings in a series of seven patients

Rheumatology ◽

10.1093/rheumatology/keg070 ◽

2003 ◽

Vol 42 (2) ◽

pp. 235-239 ◽

Cited By ~ 141

Author(s):

E. Drewe

Keyword(s):

Fusion Protein ◽

Prospective Study ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Periodic Syndrome ◽

Laboratory Findings ◽

P3485 Soluble p75 tumour necrosis factor receptor-FC fusion protein expressed by in vivo electroporation plays a protective role in experimental coxsackieviral myocarditis

European Heart Journal ◽

10.1016/s0195-668x(03)96111-2 ◽

2003 ◽

Vol 24 (5) ◽

pp. 676

Author(s):

J KIM

Keyword(s):

Fusion Protein ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Protective Role ◽

In Vivo Electroporation ◽

Fc Fusion Protein ◽

THU0096 Effect of anakinra (il-1ra) and soluble tumour necrosis factor receptor i (stnf-ri) on cellular immune function in rats

10.1136/annrheumdis-2001.973 ◽

2001 ◽

Author(s):

JE Atkinson ◽

RV House ◽

PS Cranmer ◽

AE Colucil ◽

H Davis ◽

...

Keyword(s):

Immune Function ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Cellular Immune Function ◽

Cellular Immune ◽

Increased TG/HDL‐C in female G allele carriers of rs1061622 at gene of tumour necrosis factor receptor 2 with suicidal ideation

European Journal of Clinical Investigation ◽

10.1111/eci.13322 ◽

2020 ◽

Vol 50 (11) ◽

Author(s):

Yan Jun Si ◽

Qi Wei Guo ◽

Xu Chen ◽

Mei Yang ◽

Jia Lin ◽

...

Keyword(s):

Suicidal Ideation ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Serum soluble tumour necrosis factor receptor type I concentrations independently predict prognosis in patients with breast cancer

Clinical Chemistry and Laboratory Medicine (CCLM) ◽

10.1515/cclm.2010.278 ◽

2010 ◽

Vol 48 (10) ◽

Cited By ~ 9

Author(s):

Malgorzata Fuksiewicz ◽

Maria Kowalska ◽

Beata Kotowicz ◽

Maryna Rubach ◽

Magdalena Chechlinska ◽

...

Keyword(s):

Breast Cancer ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Receptor Type ◽

Type I ◽

FRI0059 The efficacy and safety of pegylated recombinant methionyl human soluble tumour necrosis factor receptor type i (peg stnf-ri; p55) in a randomised, placebo-controlled, clinical study of patients with rheumatoid arthritis (ra)

10.1136/annrheumdis-2001.1188 ◽

2001 ◽

Author(s):

M Schiff ◽

D Furst ◽

R Fleischmann ◽

M Macri ◽

T Joh ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Study ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Receptor Type ◽

Type I ◽

Efficacy And Safety ◽

Controlled Clinical Study ◽

The tumour necrosis factor receptor superfamily member 1b 676T>G polymorphism in relation to response to infliximab and adalimumab treatment and disease severity in rheumatoid arthritis

Annals of the Rheumatic Diseases ◽

10.1136/ard.2008.088138 ◽

2008 ◽

Vol 67 (8) ◽

pp. 1174-1177 ◽

Cited By ~ 33

Author(s):

E J M Toonen ◽

M J H Coenen ◽

W Kievit ◽

J Fransen ◽

A M Eijsbouts ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Disease Severity ◽

Tumour Necrosis ◽

Adalimumab Treatment ◽

Tumour necrosis factor receptor II polymorphism and juvenile idiopathic arthritis

Rheumatology ◽

10.1093/rheumatology/41.4.462 ◽

2002 ◽

Vol 41 (4) ◽

pp. 462-465 ◽

Cited By ~ 9

Author(s):

E. Zeggini

Keyword(s):

Juvenile Idiopathic Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽